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DISCUSSION
Dr Mellick T. Sykes (San Antonio, Tex). Dr Biuckians and
his mentors in Norfolk are to be commended for this study, which
analyzes a 6-month series of hemodialysis access creation in the
KDOQI – Fistula First era. The specific focus is the natural history
of autologous fistulas created as first-time hemodialysis access
utilizing the National Kidney Foundation’s DOQI guidelines.
The fate of these 80 study patients over the first postop year is
grimly familiar to members of Southern Vascular. Summarizing
the take-home points,
● “Early referral” is a myth, with 4/5 patients already on catheter
dialysis before referral.
● Despite K/DOQI enthusiasm, at 1 year after fistula creation:
X 40% (32/80) of fistulas have never been used – 25% (20/80)
because they failed primarily (16) or after an intervention
before use (4); 15% (12/80) because the patient died or
found another solution although the fistula was patent.
X 13% (10/80) were used at least once, but abandoned despite
interventions
X 48% (38/80) (less than half) were functional: (11% (9/80)
worked w/o intervention – the “perfect” fistula; 37% (29/
80) worked at the cost of 50 interventions in this subgroup,
and 113 additional interventions in the original group of 80
● Maturation time was slow, interventions frequent, actual suc-
cessful use the minority:
Is this the future? Is this the maintenance-free life that the
KDOQI brochures depict? Have we bought swamp land in Flor-
ida? This does not seem intuitively different than the pre-KDOQI
days?
The authors conclude that (1) successful AVF maturation is
slower than previously reported, with a significant failure rate
despite aggressive intervention; (2) that a new paradigm may be
necessary; and (3) that KDOQI probably does not have the an-
swer. But have they – or any of us – really read the KDOQI fine
print?
I must say that I am not a huge fan of KDOQI:
● I resent directives from non-surgeons and nurses, who I picture
sifting papers in a board room and directing surgical judgment
from afar.
● I believe that KDOQI “scorecards” are unprofessional and
embarrassing.
● I do not think that vein-at-any-cost is best for the patient, and
take secret pleasure, if no forearm veins are evident, in placing a
good old-fashioned loop graft like God intended.
● I believe that KDOQI has replaced the promiscuous use of
prosthetic grafts by the equally promiscuous use of central
catheters and percutaneous intervention – by radiologists, neph-
rologists, and vascular surgeons alike.
However, the KDOQI recommendations simply represent a
classic and early example of the effect of evidence based medicine
can and will have on our specialty.
We created it: Members of this Society were the vascular
surgeons on the 2000 and 2006 work groups. KDOQI brochures
quote our literature. They simply summarize what is available out
there. If we believe we have a better vascular access mousetrap, we
only need publish it. They cannot read our minds!
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Moreover, no doubt with Alan Lumsden’s help, the 2006 guide-
lines reflect common practice wisdom, and recognizes the problems
noted in this paper: noting that “ theWorkGroup recognizes that in
some cases, the “fistula first at all costs” approachmay not be themost
cost-effective or optimal for each individual. A functional fistula is the
goal, not the insertion of a fistula with a poor chance at maturing. A
graft can be used as a “planned bridge” to a fistula ”1
Questions for the authors:
1. We have found open revision more lasting than endovascular
interventions, particularly in peri-arterial stenosis. Could you
comment?
2. How did this group compare with AVGs created at the same
time?
3. What is your protocol for follow-up? Who followed the patient,
and how? We now duplex fistulas monthly until use;
4. Who decided when to cannulate? When to intervene? When to
abandon a site?
5. In particular, how do you explain the unusual delay in cannu-
lation in your series? Were patients simply lost in the system?
6. Finally, what modifications do you recommend be made in the
DOQI guidelines?
I commend the authors for a lucid presentation of this impor-
tant data.
Dr Andre Biuckians. Thank you for those comments. In
regards to your first question, a majority of the revisions performed
were percutaneous but when we compared abandoned fistulas with
functioning fistulas, functioning fistulas did receive some type of
open revision more often. However, we did not analyze whether
open or percutaneous interventions resulted in improved out-
comes in this series. The practice prefers percutaneous interven-
tions at the time of the diagnostic fistulogram and the fact that a
majority of fistulas in the abandoned group received only a percu-
taneous intervention may be a reflection of unsalvageable fistulas
rather than failed percutaneous interventions.
In regards to the comparison to first time grafts, we have
submitted an abstract to the Society of Vascular Surgery’s annual
meeting this summer that summarizes the results, but I can give
you a little snapshot. We found that the primary reason a patient
received a graft as opposed to a fistula was due to inadequate vein
size. When we looked at their patency in comparison, primary
patency in the grafts was certainly worse, but secondary patency
after intervention was better at 68% at 1 year. In addition, the
number of interventions performed in the graft group was essen-
tially identical to the number of interventions performed in the
fistula group, and so we achieved better patency results with a
similar intervention rate.
In terms of your question regarding follow-up, there is no
protocol at this time. After surgery, patients are typically seen at
4-week intervals until the fistula is ready for use, so the surgeon is
in charge of ensuring that these fistulas are maturing. We do not
use duplex scanning on a regular basis and rather rely on clinical
examination. If there is any question about whether the fistula will
work, we will proceed with a fistulogram and intervene at that same
setting.
And lastly, in regards to the NKF-DOQI recommendations, I
think that the guidelines should focus on establishing any access
that will be usable in a reasonable amount of time in order to
decrease catheter dependence. It has been shown that catheter
dependence carries significant risks and if we are trying to put
fistulas in every patient in order to achieve a high level of autolo-
gous fistula use, in our experience, we are going to have a signifi-
cant number of patients that are just waiting a long time with a
catheter in place.
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INVITED COMMENTARY
Thomas G. Lynch, MD, and Troy J. Plumb, MD, Omaha, Neb
In this series of patients receiving an initial, autogenous arterio-
venous fistula (AVF), the reported primary patency at 1 year (36%) is
low relative to other series. The authors attribute this to an
aggressive approach to the placement of autogenous fistulas. In
concluding, they note that adherence to the Kidney Disease Out-
comes Quality Initiative (K/DOQI) strategy may not result in
increased AVF utilization and may prolong catheter dependence.
While the manuscript describes their experience after publica-
tion of the K/DOQI guidelines, not all elements of the guidelines
were followed. For the placement of an AVF to occur in a timely
manner: (1) patients must have access to the healthcare system; (2)
chronic kidney disease must be recognized by primary providers;
(3) patients must be referred to nephrologists for pre-dialysis care;
and (4) nephrologists must make timely referral for hemodialysis
access assessment and placement. For the patients in this series,
there was a breakdown in one or more of these elements, as 78% of
those referred for placement of first time vascular access were
already dialyzing via central venous catheters.
Once surgical referral occurs, K/DOQI emphasizes the impor-
tance of preoperative vein mapping, arterial assessment, and the
preferred order of access placement to optimize the chance of matur-
ing a functional fistula. Based on current literature and K/DOQI
guidelines, arteries should be at least 2 mm and veins at least 2.5 mm,
in diameter.1,2 The order of preferred AVF placement is radiocephalic
 brachiocephalic brachiobasilic arteriovenous grafts.1
The authors are to be commended for a critical review of their
experience, which highlights opportunities for change that may ulti-
mately impact long-term functional patency. The study indicates that
there is, perhaps, a role for a unified approach to dialysis access. It is
possible that patency may have been adversely impacted by the dis-
parate approach of the 15 surgeons in this group and their lack of
adherence to K/DOQI guidelines. Some of the surgeons proceeded
directly to use of a prosthetic graft when patients were not candidates
for radiocephalic or brachiocephalic fistulas, instead of attempting a
brachiobasilic fistula. Only 76% of patients in this study underwent
preoperativemapping.Despitemapping, veinswith diameters as small
as 1.3 mm were used for fistulas. Even after access had been placed,
times to cannulation seem prolonged.
While we have a limited understanding of why fistulas fail, we
do know that fistulas are more likely to fail when minimum
requirements are not met. A standardized approach is crucial not
only for clinical outcomes, but for our ability to study access
outcomes. The goal is not to simply place an AVF, but to place an
access that can be utilized for hemodialysis.
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